The National Institute on Drug Abuse through the NIH HEAL Initiative will fund development of SiteOne's selective NaV1.8 inhibitor for the treatment of pain SOUTH SAN FRANCISCO, Calif., May 18, 2023 /PRNewswire/ -- SiteOne Therapeutics, Inc., a clinical-stage biopharmaceutical company...
News Ticker
- [ May 27, 2023 ] Senior Director, Head of Medical Affairs – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Clinical Data Manager – Revolution Medicines – Redwood City, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Postdoc or Staff Computational Biologist: Quantitative Evolutionary Genomics and Ecology in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Assistant: Next Generation Sequencing and CRISPR in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Associate II, Analytical Development, Bioassays – Vir Biotechnology, Inc. – San Francisco, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
